tiprankstipranks
Trending News
More News >
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
US Market
Advertisement

Benitec Biopharma (BNTC) Income Statement

Compare
310 Followers

Benitec Biopharma Income Statement

Last quarter (Q1 2026), Benitec Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Benitec Biopharma's net income was $-13.56M. See Benitec Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 75.00K$ 73.00K$ 59.00K
Gross Profit
$ -396.00K$ -343.00K$ -306.00K$ 64.00K$ -64.00K
Operating Expenses
$ 41.37M$ 22.25M$ 18.77M$ 17.92M$ 13.53M
Depreciation and Amortization
$ 69.33K$ 343.00K$ 381.00K$ 392.00K$ 424.00K
EBITDA
$ -41.70M$ -21.41M$ -19.15M$ -17.85M$ -13.45M
Operating Income
$ -41.77M$ -22.60M$ -19.08M$ -17.85M$ -13.60M
Other Income/Expenses
$ 3.85M$ 847.00K$ -481.00K$ -354.00K$ -286.00K
Pretax Income
$ -37.92M$ -21.75M$ -19.56M$ -18.21M$ -13.88M
Net Income
$ -37.92M$ -21.75M$ -19.56M$ -18.21M$ -13.88M
Per Share Metrics
Basic EPS
$ -1.05$ -2.68$ -14.12$ -19.31$ -27.27
Diluted EPS
$ -1.05$ -2.68$ -14.12$ -19.31$ -27.27
Weighted Average Shares Outstanding
36.21M 10.26M 1.39M 1.92M 1.01M
Weighted Average Shares Outstanding (Diluted)
36.21M 10.28M 1.39M 1.92M 1.01M
Currency in USD

Benitec Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis